Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1BELIMUMAB
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
2Belimumab 1 mg/kg
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
3Belimumab 10 mg
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 222 💬
4Belimumab 10 mg/kg
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 43, 46, 49 💬
5Belimumab 10 mg/kg plus standard therapy
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
6Belimumab 100 mg SC
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
7Belimumab 10mg/kg
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
8Belimumab 200 mg SC
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
9Belimumab 200 mg/mL
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
10Belimumab 4 mg/kg
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
11Belimumab for IV
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
12Belimumab for SC
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
13Belimumab in SLE patients / Rituximab in RA patients
(Benlysta)		[2] Belimumab (Benlysta),
Rituximab		[2] Rituximab ,
Belimumab (Benlysta) 💬 		[2] MS4A1,
TNFSF13B 💬 		[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
14Belimumab Injection
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
15Belimumab Injection [Benlysta][1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
16Belimumab or benlysta[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
17Belimumab plus Early Vaccination
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
18Belimumab plus Late Vaccination
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
19Benlysta[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[5] 43, 49, 53, 66, 222 💬
20Benlysta (belimumab)[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[4] 11, 49, 53, 222 💬
21BENLYSTA - 120 MG - POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 120 MG 1 FLACONCINO[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 53 💬
22Benlysta 400 mg powder for concentrate for solution for infusion[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 43, 49 💬
23Benlysta 400 mg powder for concentrate for solution for infusions[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
24Benlysta 400mg polvere per concentrato per soluzione per infusione[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 43 💬
25BENLYSTA? (belimumab)[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
26Benlysta®[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 49, 222 💬
27BENLYSTA® (belimumab)[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 11, 66, 222 💬
28BENLYSTA™ (belimumab)[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
29Combination of Rituximab with subcutaneous belimumab
(Benlysta)		[2] Belimumab (Benlysta),
Rituximab		[2] Rituximab ,
Belimumab (Benlysta) 💬 		[2] MS4A1,
TNFSF13B 💬 		[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 63 💬
30Combination Product: Belimumab
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
31GSK1550188 (Belimumab)
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 222 💬
32HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 49, 53 💬
33LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA®[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
34Prednisone and Belimumab
(Benlysta)		[2] Belimumab (Benlysta),
Prednisone		[2] Prednisone ,
Belimumab (Benlysta) 💬 		[2] NR3C1,
TNFSF13B 💬 		[5] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬[1] 300 💬
35SC belimumab 200 mg
(Benlysta)		[1] Belimumab (Benlysta)[1] Belimumab (Benlysta) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬